Absci to Participate in Upcoming Investor Conferences
Absci (Nasdaq: ABSI), a data-first generative AI drug creation company, has announced its participation in multiple investor conferences in November 2024. The schedule includes the Truist Securities BioPharma Symposium in New York, Guggenheim Securities Inaugural Healthcare Innovation Conference in Boston, UBS Global Healthcare Conference in California, Stifel 2024 Healthcare Conference in New York, and Jefferies London Healthcare Conference in the UK. The company will participate in fireside chats and host one-on-one meetings. Live and archived webcasts will be available on Absci's investor relations website.
Absci (Nasdaq: ABSI), un'azienda di creazione di farmaci generativi basata sui dati, ha annunciato la sua partecipazione a diverse conferenze per investitori nel novembre 2024. Il programma include il Truist Securities BioPharma Symposium a New York, il Guggenheim Securities Inaugural Healthcare Innovation Conference a Boston, il UBS Global Healthcare Conference in California, il Stifel 2024 Healthcare Conference a New York e il Jefferies London Healthcare Conference nel Regno Unito. L'azienda parteciperà a discussioni informali e organizzerà incontri one-on-one. Streaming dal vivo e registrazioni delle conferenze saranno disponibili sul sito web delle relazioni con gli investitori di Absci.
Absci (Nasdaq: ABSI), una empresa de creación de medicamentos generativos basada en datos, ha anunciado su participación en múltiples conferencias para inversores en noviembre de 2024. El programa incluye el Truist Securities BioPharma Symposium en Nueva York, el Guggenheim Securities Inaugural Healthcare Innovation Conference en Boston, el UBS Global Healthcare Conference en California, el Stifel 2024 Healthcare Conference en Nueva York y el Jefferies London Healthcare Conference en el Reino Unido. La empresa participará en charlas informales y organizará reuniones uno a uno. Las transmisiones en vivo y grabadas estarán disponibles en el sitio web de relaciones con inversores de Absci.
Absci (Nasdaq: ABSI)는 데이터 중심의 생성 AI 의약품 개발 회사로, 2024년 11월에 여러 투자자 회의에 참여한다고 발표했습니다. 일정에는 뉴욕에서 열리는 Truist Securities BioPharma Symposium, 보스턴에서 열리는 Guggenheim Securities Inaugural Healthcare Innovation Conference, 캘리포니아의 UBS Global Healthcare Conference, 뉴욕의 Stifel 2024 Healthcare Conference, 그리고 영국의 Jefferies London Healthcare Conference가 포함됩니다. 회사는 대화형 세션에 참석하고 일대일 미팅을 주최할 예정입니다. 실시간 및 기록된 웹캐스트는 Absci의 투자자 관계 웹사이트에서 확인할 수 있습니다.
Absci (Nasdaq: ABSI), une entreprise de création de médicaments génératifs axée sur les données, a annoncé sa participation à plusieurs conférences pour investisseurs en novembre 2024. Le programme comprend le Truist Securities BioPharma Symposium à New York, le Guggenheim Securities Inaugural Healthcare Innovation Conference à Boston, le UBS Global Healthcare Conference en Californie, le Stifel 2024 Healthcare Conference à New York et le Jefferies London Healthcare Conference au Royaume-Uni. L'entreprise participera à des discussions informelles et organisera des réunions individuelles. Des webinaires en direct et enregistrés seront disponibles sur le site des relations avec les investisseurs d'Absci.
Absci (Nasdaq: ABSI), ein datenorientiertes Generative AI-Unternehmen zur Arzneimittelentwicklung, hat seine Teilnahme an mehreren Investorenkonferenzen im November 2024 angekündigt. Der Zeitplan umfasst das Truist Securities BioPharma Symposium in New York, die Guggenheim Securities Inaugural Healthcare Innovation Conference in Boston, die UBS Global Healthcare Conference in Kalifornien, die Stifel 2024 Healthcare Conference in New York und die Jefferies London Healthcare Conference im Vereinigten Königreich. Das Unternehmen wird an informellen Gesprächen teilnehmen und Einzelgespräche veranstalten. Livestreams und aufgezeichnete Webcasts werden auf der Investoren-Relations-Website von Absci verfügbar sein.
- None.
- None.
VANCOUVER, Wash. and NEW YORK, Oct. 24, 2024 (GLOBE NEWSWIRE) -- Absci Corporation (Nasdaq: ABSI), a data-first generative AI drug creation company, today announced the company will be participating in the following upcoming investor conferences.
- Truist Securities BioPharma Symposium (New York, NY)
Hosting 1x1 meetings on Thursday, November 7
- Guggenheim Securities Inaugural Healthcare Innovation Conference (Boston, MA)
Fireside chat on Monday, November 11 at 10:00 a.m. Eastern Time / 7:00 a.m. Pacific Time, and hosting 1x1 meetings
- UBS Global Healthcare Conference (Rancho Palos Verdes, CA)
Fireside chat on Wednesday, November 13 at 10:15 a.m. Eastern Time / 7:15 a.m. Pacific Time, and hosting 1x1 meetings
- Stifel 2024 Healthcare Conference (New York, NY)
Fireside chat on Monday, November 18 at 1:50 p.m. Eastern Time / 10:50 a.m. Pacific Time, and hosting 1x1 meetings
- Jefferies London Healthcare Conference (London, UK)
Hosting 1x1 meetings on Tuesday, November 19 and Wednesday, November 20
Interested parties may access live and archived webcasts of the fireside chat sessions on the company’s investor relations website at: investors.absci.com.
About Absci
Absci is a data-first generative AI drug creation company that combines AI with scalable wet lab technologies to create better biologics for patients, faster. Our Integrated Drug Creation™ platform unlocks the potential to accelerate time to clinic and increase the probability of success by simultaneously optimizing multiple drug characteristics important to both development and therapeutic benefit. With the data to train, the AI to create, and the wet lab to validate, we can screen billions of cells per week, allowing us to go from AI-designed candidates to wet lab-validated candidates in as little as six weeks. Absci’s headquarters is in Vancouver, WA, with our AI Research Lab in New York City and an Innovation Center in Zug, Switzerland. Visit www.absci.com and follow us on LinkedIn (@absci), X (Twitter) (@Abscibio), and YouTube.
Investor Contact
Alex Khan
VP, Finance & Investor Relations
investors@absci.com
Media Contact
press@absci.com
FAQ
What investor conferences will Absci (ABSI) attend in November 2024?
When is Absci's (ABSI) fireside chat at the UBS Global Healthcare Conference?
Where can investors watch Absci's (ABSI) conference presentations?
Which international conference will Absci (ABSI) attend in November 2024?
